GB BPR Renewals: What Cleaning and Disinfectant Manufacturers Need to Know Now

The regulatory landscape for biocidal products in Great Britain is moving through one of its most consequential periods since Brexit. If you manufacture, formulate, or place cleaning or disinfectant products on the GB market, there are active deadlines, unresolved decisions, and structural changes underway that require attention now, not at the next annual review.
‍

What is GB BPR?

Following Brexit, Great Britain adopted its own version of the EU Biocidal Products Regulation, known as GB BPR. It governs any substance or mixture intended to destroy, deter, or neutralise harmful organisms, covering a broad range of products including disinfectants, preservatives, and pest control formulations.

For manufacturers of household and professional cleaning products, the most immediately relevant category is product type 2 (private area disinfectants), product type 4 (food and feed area disinfectants), and product type 6 (preservatives used during storage). Many standard cleaning formulations fall within these or adjacent categories.

Like its EU counterpart, GB BPR requires that all active substances used in biocidal products hold an approved status. Products containing non-approved or expired active substances cannot lawfully be placed on the market.
‍

The renewal window that matters

Under GB BPR, active substance approvals must be renewed, and the renewal application must be submitted at least 550 days before the existing approval expires. That lead time is not generous. For manufacturers whose products rely on multiple active substances, tracking renewal timelines across a full portfolio is a material compliance task.

The situation became notably more complex in early 2026. Draft legislation proposed by the UK Health and Safety Executive (HSE) in February 2026 included a significant transitional measure: approvals for 173 active substances that would otherwise expire between June 2026 and July 2031 are to be automatically extended to 31 July 2031, provided a renewal application has already been submitted. This provides breathing room for manufacturers with applications in the pipeline, but it does not remove the obligation to have applied.

If no renewal application has been submitted and an active substance approval lapses, the products relying on that substance cannot legally remain on the market. That is a direct commercial risk.
‍

The ethanol question

One of the more consequential unresolved issues sits with ethanol, one of the most widely used active substances in disinfectant formulations. At the end of 2025, the EU's Biocidal Products Committee failed to reach consensus on renewing ethanol's approval as a biocidal active substance, pushing its opinion to May 2026. The GB position, while separate, watches this closely.

For manufacturers whose disinfectant ranges rely on ethanol as a primary active, this ongoing uncertainty makes forward planning for formulation and labelling more difficult. It does not signal an imminent ban, but it does mean the situation requires active monitoring rather than assumption.
‍

Emergency authorisations

The February 2026 draft legislation also proposed extending the duration of emergency authorisations for unauthorised biocidal products. Under the proposal, such authorisations could remain in place for up to 550 days, or until a product authorisation decision is made, whichever is sooner. This is relevant for manufacturers who have sought emergency routes to market while full authorisation is pending.
‍

What this means in practice

For manufacturers, the immediate priorities are:

First, map your active substance portfolio against current GB BPR approval status and expiry dates. The HSE maintains a searchable register. This is not an activity to delegate without oversight.

Second, confirm whether renewal applications have been submitted for any substances approaching expiry. The 550-day lead time means substances expiring in 2027 require applications now.

Third, review product labelling for CLP compliance. GB BPR sits alongside the GB Classification, Labelling and Packaging Regulation, which is itself subject to proposed amendments in the same February 2026 draft legislation. Label reviews should account for both sets of changes simultaneously.

Fourth, if any products in your range contain ethanol as a listed biocidal active, flag this for monitoring. The May 2026 EU committee opinion, while not binding on GB, is likely to influence the direction of GB policy.
‍

The broader context

GB BPR is one of several regulatory frameworks that have diverged from EU equivalents since Brexit, creating a dual-compliance challenge for manufacturers supplying both markets. While the GB and EU frameworks remain broadly aligned in intent, they are diverging in detail, particularly around active substance timelines, emergency authorisation rules, and labelling requirements.

For contract manufacturers supplying brands operating across both GB and EU markets, this divergence means that a single compliance strategy no longer works. Regulatory status needs to be tracked separately for each market, and formulation decisions that satisfy one jurisdiction may not satisfy the other.

The manufacturers who navigate this period well will be those who treat regulatory tracking as a standing operational function, not a reactive exercise triggered by a compliance failure. The deadlines are known. The risks are documented. The time to act on them is now.

‍